Implications of extreme serum neurofilament light chain levels for the management of patients with relapsing multiple sclerosis

Background: Serum neurofilament light chain (sNfL) is a promising biomarker to complement the decision-making process in multiple sclerosis (MS) patients. However, although sNfL levels are able to detect disease activity and to predict future disability, the growing evidence has not yet been transla...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Sinah Engel, Maria Protopapa, Falk Steffen, Vakis Papanastasiou, Christoforos Nicolaou, Michalis Protopapas, Frauke Zipp, Stefan Bittner, Felix Luessi
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	SAGE Publishing 2021-04-01
Sarja:	Therapeutic Advances in Neurological Disorders
Linkit:	https://doi.org/10.1177/17562864211001977
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!